The renal function trajectory in clinical trial design: challenges and opportunities

被引:0
|
作者
Rosansky, Steven [1 ]
Glassock, Richard [2 ]
机构
[1] Williams Jenning Brian Dorn Vet Adm Hosp, Dorn Res Inst, 6439 Garners Ferry Rd, Columbia, SC 29209 USA
[2] UCLA, David Geffen Sch Med, Dept Med, Los Angeles, CA USA
关键词
D O I
10.1016/j.kint.2024.07.023
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The changes in renal function over time as surrogate endpoints for new drug trials are complicated by many factors, including the oftenexpected initial decrease in estimated glomerular filtration rate when a new drug is started. Two articles in the journal address this challenge, but multiple other challenges are explored in this commentary. To maximize the benefits of expensive new drugs that may slow decline in renal function, these drugs should be reserved for those patients who have a high probability of rapid loss of kidney function.
引用
收藏
页码:565 / 568
页数:4
相关论文
共 50 条
  • [21] Sharing clinical trial data on patient level: Opportunities and challenges
    Koenig, Franz
    Slattery, Jim
    Groves, Trish
    Lang, Thomas
    Benjamini, Yoav
    Day, Simon
    Bauer, Peter
    Posch, Martin
    BIOMETRICAL JOURNAL, 2015, 57 (01) : 8 - 26
  • [22] Challenges in clinical trial design in inflammatory arthritis
    O'Dell, James R.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2010, 24 (04): : 457 - 461
  • [23] Renal function trajectory over time and adverse clinical outcomes
    Badrul Munir Sohel
    Nahid Rumana
    Masaki Ohsawa
    Tanvir Chowdhury Turin
    Martina Ann Kelly
    Mohammad Al Mamun
    Clinical and Experimental Nephrology, 2016, 20 : 379 - 393
  • [24] Renal function trajectory over time and adverse clinical outcomes
    Sohel, Badrul Munir
    Rumana, Nahid
    Ohsawa, Masaki
    Turin, Tanvir Chowdhury
    Kelly, Martina Ann
    Al Mamun, Mohammad
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2016, 20 (03) : 379 - 393
  • [25] RCTs and other clinical trial designs in Ayurveda: A review of challenges and opportunities
    Gautama, Pushya A.
    JOURNAL OF AYURVEDA AND INTEGRATIVE MEDICINE, 2021, 12 (03) : 556 - 561
  • [26] Challenges in Cardiomyopathy Gene Therapy Clinical Trial Design
    Satish, Tejus
    Hong, Kimberly N.
    Kaski, Juan Pablo
    Greenberg, Barry H.
    JACC-HEART FAILURE, 2025, 13 (01) : 154 - 166
  • [27] Signal transduction therapy: Challenges to clinical trial design
    Hussain, Syed A.
    Rea, Daniel W.
    James, Nicholas D.
    Palmer, Daniel H.
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2007, 2 (01) : 21 - 30
  • [28] The effect of liraglutide on renal function: A randomized clinical trial
    von Scholten, Bernt J.
    Persson, Frederik
    Rosenlund, Signe
    Hovind, Peter
    Faber, Jens
    Hansen, Tine W.
    Rossing, Peter
    DIABETES OBESITY & METABOLISM, 2017, 19 (02): : 239 - 247
  • [29] Enrollment in a clinical trial improves renal function.
    Fassett, RG
    Coombes, JS
    Purse, LM
    Watts, M
    Chugg, KL
    Geraghty, DP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 768A - 768A
  • [30] Design, Control, and Clinical Applications of Magnetic Actuation Systems: Challenges and Opportunities
    Huo, Yingxin
    Yang, Lidong
    Xu, Tiantian
    Sun, Dong
    ADVANCED INTELLIGENT SYSTEMS, 2025, 7 (03)